Application of Nanomaterials Targeting Immune Cells in the Treatment of Chronic Inflammation
International Journal of Nanomedicine · 2024-12 · Volume 19 · 13925-13946
DOI: 10.2147/ijn.s497590 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2024-12. Verfasst von Zhen Ci und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Implantology, Hospital of Stomatology, Jilin University, Changchun, 130021, People's Republic of China. Hauptthemen laut MEDLINE: Inflammation. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Chronic inflammation is a common characteristic of all kinds of diseases, including autoimmune diseases, metabolic diseases, and tumors. It is distinguished by the presence of low concentrations of inflammatory factors stimulating the body for an extended period, resulting in a persistent state of infection. This condition is manifested by the aggregation and infiltration of mononuclear cells, lymphocytes, and other immune cells, leading to tissue hyperplasia and lesions. Although various anti-inflammatory medications, including glucocorticoids and non-steroidal anti-inflammatory drugs (NSAIDs), have shown strong therapeutic effects, they lack specificity and targeting ability, and require high dosages, which can lead to severe adverse reactions. Nanoparticle drug delivery mechanisms possess the capacity to minimize the effect on healthy cells or tissues due to their targeting capabilities and sustained drug release properties. However, most nanosystems can only target the inflammatory sites rather than specific types of immune cells, leaving room for further improvement in the therapeutic effects of nanomaterials. This article reviews the current research progress on the role of diverse immune cells in inflammation, focusing on the functions of neutrophils and macrophages during inflammation. It provides an overview of the domestic and international applications of nanomaterials in targeted therapy for inflammation, aiming to establish a conceptual foundation for the utilization of nanomaterials targeting immune cells in the treatment of chronic inflammation and offer new perspectives for the avoidance and management of inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Implantology, Hospital of Stomatology, Jilin University, Changchun, 130021, People's Republic of China.
- Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, Hospital of Stomatology, Jilin University, Changchun, 130021, People's Republic of China.
- Department of Oral Biology, Hospital of Stomatology, Jilin University, Changchun, 130021, People's Republic of China.
Zitieren
APA
Ci, Z., Wang, H., Luo, J., Wei, C., Chen, J., Wang, D., & Zhou, Y. (2024). Application of Nanomaterials Targeting Immune Cells in the Treatment of Chronic Inflammation. International Journal of Nanomedicine, Volume 19, 13925-13946. https://doi.org/10.2147/ijn.s497590
Vancouver
Ci Z, Wang H, Luo J, Wei C, Chen J, Wang D, et al. Application of Nanomaterials Targeting Immune Cells in the Treatment of Chronic Inflammation. International Journal of Nanomedicine. 2024;Volume 19:13925-13946. doi:10.2147/ijn.s497590
BibTeX
@article{Ci2024,
author = {Ci, Zhen and Wang, Hanchi and Luo, Jiaxin and Wei, Chuqiao and Chen, Jingxia and Wang, Dongyang and Zhou, Yanmin},
title = {Application of Nanomaterials Targeting Immune Cells in the Treatment of Chronic Inflammation},
journal = {International Journal of Nanomedicine},
year = {2024},
volume = {Volume 19},
pages = {13925--13946},
doi = {10.2147/ijn.s497590}
}
EUVIMED